Mandate

Vinge has advised Lendify in connection with a Swedish securitisation

May 22, 2017 Banking and Finance

Lendify AB (”Lendify”), a P2P-lending platform, has issued SEK 200,000,000 bonds on 30 May 2017 through its wholly-owned subsidiary Lendify Sweden 1 AB (publ).

The bonds have a tenor of three years and an annual interest rate of three-months Stibor + 5 %. The bonds are intended to be listed on the regulated market NDX, operated by Nordic Growth Market AB.

The bonds are backed by a portfolio of promissory notes issued by consumers in Sweden in favour of Lendify. The payment of interest and repayment of principal on the bonds are based on the cashflow from the portfolio. The entire documentation is governed by Swedish law and the collateral is held by Intertrust (Sweden) AB, who is also acting as agent for the bondholders.

Together with the management of the company, Carnegie Investment Bank AB (publ) as arranger and issuing agent and its legal advisors, Vinge acted for Lendify in the structuring and documentation of the transaction. Vinge’s team consisted of Jonas Johansson, Emma Stuart-Beck, Albert Wållgren, Louise Nordkvist and André Isacson.

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026